Adsorption, system release and antimicrobial properties of chlorhexidine on nanohydroxyapatite...

24
ADSORPTION, SYSTEM RELEASE AND ANTI-MICROBIAL PROPERTIES OF CHLORHEXIDINE ON NANOHYDROXYAPATITE COATINGS J Barros , L Grenho, CM Manuel, OC Nunes, LF Melo, FJ Monteiro, MP Ferraz [email protected] INEB Instituto de Engenharia Biomédica Universidade do Porto Porto, Portugal INEB - Instituto de Engenharia Biomédica LEPAE Laboratory for process, environmental and energy engineering Universidade do Porto, Porto, Portugal

Transcript of Adsorption, system release and antimicrobial properties of chlorhexidine on nanohydroxyapatite...

ADSORPTION, SYSTEM RELEASE AND ANTI-MICROBIAL PROPERTIES OF CHLORHEXIDINE ON NANOHYDROXYAPATITE COATINGS

J Barros, L Grenho, CM Manuel, OC Nunes,

LF Melo, FJ Monteiro, MP Ferraz

[email protected]

INEB – Instituto de Engenharia Biomédica

Universidade do Porto

Porto, Portugal

INEB - Instituto de Engenharia Biomédica

LEPAE – Laboratory for process, environmental and energy engineering Universidade do Porto, Porto, Portugal

Nanohydroxyapatite

Biocompatibility Bioactivity

Osteocondutivity Osteoinduction

Ferraz et al, (2004). Journal of Applied Biomaterials & Biomechanics

Antimicrobial activity

Frequency of main pathogenic species among

orthopedic clinical isolates of implants-

associated infections.

Darouise. (2001). Clinical Infections Diseases

Campoccia et al. (2006). Biomaterials

Devices-associated infections

Biofilm – is a structured community of bacterial cells enclosed in a self-produced polymeric matrix and adherent to an inert or living surface.

Biofilm formation

Manuel. 2007. Thesis doctoral.

Chlorhexidine digluconate (CHX)

Anti-microbial activity:

• Gram negative bacteria

• Gram positive bacteria

• Fungi

Souza et al. (2011). Colloids and Surfaces B: Biointerfaces.

Acting Mechanism

Souza et al. (2011). Colloids and Surfaces B: Biointerfaces.

To study the adsorption of chlorhexidine digluconate (CHX) to

nanohydroxyapatite discs sintered at 830˚C (nanoHA830)

To study the release system from these coatings

To evaluate the in vitro anti-adhesive and anti-bacterial

activity of CHX + nanoHA coatings

Purposes

Materials and methods

150 mg of nanoHA powder

1- Preparation of nanohydroxyapatite discs heat-treated at 830˚C

Sintering at 830˚C

Pressing at 2 MPa

nanoHA discs heat-treated at 830˚C (nanoHA830)

Materials and methods

1. Adsorption of CHX on nanoHA830

Different solutions of CHX (5-1500mg/L) were prepared by

diluting an aqueous stock solution of 20% chlorhexidine

digluconate in sterile deionized water.

Adsorption experiments were carried out in a

batch system using nanoHA sintered at 830˚C

discs. The nanoHA830 discs were placed in 6-well

polystyrene microtiter plates and incubated with

each CHX concentration prepared previously and

moderately shaken for 24 h at 37˚C.

5 50 100 500 1500

UV–vis spectrophotometry, 254 nm wavelength

Materials and methods

2. System release

1500 mg/L CHX + nanoHA830 Sampling time (h)

1, 24, 48, 72, 120, 168, 240 and 312

24 to 24 h

Fresh 0.9%NaCl

UV–vis spectrophotometry, 254 nm wavelength

Materials and methods 3. Minimum inhibitory concentration

Minimum inhibitory concentration (MIC) of CHX were determined for S. aureus ATCC 25923 by

micro-dilution method, according to what was defined by Clinical and Laboratory Standards

Institute. The MIC is the lowest concentration of a drug that prevents growth of a particular

pathogen.

Colune

1 Muller-Hinton Broth (200 µL)

2 Sterile water (200 µL)

4 Bacterial suspension (200 µL)

6-12 Chlorhexidine digluconate concentrations (20 µL) + Bacterial suspension (180 µL)

1- 150 mg/L CHX

Materials and methods 4. Antimicrobial studies

• Anti-adhesive properties • Anti-bacterial activity

Colony Forming Units

CFUs/mm2

CHX + nanoHA830

Pure nanoHA830

1,5×108/mL

24h/37°C

Batch system

120 rpm

Ultra-sonic batch

Bacterial detachment

Over time the bacteria/ml

was measured at 640 nm.

Suspension was placed in

96-well plates.

Results 1. Isotherm adsorption

Adsorbed CHX onto nanoHA discs exhibited Langmuir-type adsorption isotherm, with

a good correlation.

0,E+00

5,E-04

1,E-03

2,E-03

2,E-03

0 500 1000 1500 2000

Qe

(mg/

mm

2)

Ce (mg/L)

Langmuir model

2.6 × 10-3

1.5 × 10-3

1.0 × 10-3

5.0 × 10-4

Qe =

R2 = 0.9974

Ce

552.71Ce + 74915

Qe – Amount of CHX adsorved per unit area of nanoHA discs

Ce – Equilibrum CHX concentration, after incubation

Results 1.2 Materials characterization

Attenuated total reflectance (ATR) – FTIR.

0

20

40

60

80

100

120

4000 3700 3400 3100 2800 2500 2200 1900 1600 1300 1000 700 400

% t

ran

smit

ance

(a.

u)

Wavenumbers (cm-1)

nanoHA830

5 mg/L CHX+nanoHA830

50 mg/L CHX+nanoHA830

100 mg/L CHX+nanoHA830

500 mg/L CHX+nanoHA830

1500 mg/L CHX+nanoHA830

*

*

•OH-

*PO4-3

*

*

*

*

Results 1.3 Materials characterization

5 mg/L CHX + nanoHA830

500 mg/L CHX + nanoHA830 100 mg/L CHX + nanoHA830 1500 mg/L CHX + nanoHA830

nanoHA830 50 mg/L CHX + nanoHA830

Results 2.System release

The 1500 mg/L CHX+nanoHA disc coatings showed a slow release over time for a period of several

days, being the amount of CHX released higher than MIC values for bacteria used.

0

4

8

12

16

20

24

28

0 50 100 150 200 250 300 350

Rel

ease

acc

um

ula

tive

co

nce

ntr

atio

n

(mg/

L)

Time (h)

MIC = 4 mg/L

1,00E+07

1,00E+08

1,00E+09

1,00E+10

3 24 48 72 120 144 168 172 196

Bac

teri

a d

ensi

ty (

bac

teri

a/m

L)

Time (h)

NanoHA830

1500 mg/L CHX + nanoHA830

500 mg/L CHX + nanoHA830

100 mg/L CHX + nanoHA830

50 mg/L CHX + nanoHA830

5 mg/L CHX + nanoHA830

1 × 107

1 × 1010

1 × 109

1 × 108

Results 3. Anti-bacterial activity

The CHX released from 1500 mg/L CHX + nanoHA and 500 mg/L CHX + nanoHA coatings inhibited the bacteria growth

during 9 days, being the amount bacteria/mL lower than initial bacteria density added.

•p 0.05, significant reduction compared to pure nanoHA830, according to Tukey HSD

*p> 0.05, no significant differences reduction compared to initial bacteria density added, according to Tukey HSD

*

• •

Initial bacteria density added

100%

70,6%

22,4%

0% 0% 0

10

20

30

40

50

60

70

80

90

100

nanoHA830 5 mg/L CHX + nanoHA830

100 mg/L CHX + nanoHA830

500 mg/L CHX + nanoHA830

1500 mg/L CHX + nanoHA830

Per

cen

tage

of

bac

teri

a ad

her

ed o

n s

urf

ace

s (%

)

Surfaces

Results 3. Anti-adhesive properties

During 24 hours of incubation were evaluated the anti-adhesive properties for 1500 mg/L, 500 mg/L,

100 mg/L and 5 mg/L CHX+nanoHA coating compared with pure nanoHA830 surface.

*

*p 0.05, significant bacteria adhesion compared to pure nanoHA830, according to Tukey HSD

Conclusions

Adsorbed CHX onto nanoHA discs exhibited Langmuir-type adsorption isotherms with

a good correlation (R2 = 0.9974).

The chlorhexidine digluconate was incorporated into the coatings via formation of a

chlorhexidine phosphate precipitate onto the nanoHA discs.

The morphological effect studied by SEM showed that CHX did not cause

morphological changes to the nanoHA surfaces.

The 1500 mg/L CHX-nanoHA disc coatings showed a slow release over time for several

days, being the amount of CHX released higher than MIC values for S. aureus ATCC 25923

(MIC=4 mg/L).

The 1500 mg/L CHX + nanoHA and 500 mg/L CHX + nanoHA coatings showed strong

anti-bacterial activity and the other coatings showed low anti-bacterial activity.

All CHX + nanoHA830 disc coatings exhibited strong anti-adhesive properties.

Different coatings were tested, showing anti-microbial activity, revealing that binding

of CHX to nanoHA discs did not affect anti-microbial activity of CHX.

These results showed that CHX + nanoHA disc coatings might be a good alternative to

medical devices implants.

Conclusions

Perform coatings surfaces characterization (XRD, AFM, zeta potential and angle

contact).

Perform more anti-microbiological tests with other relevant bacterial strains.

Perform citotoxicity tests with the coatings.

Ongoing work

Acknowledgements

Supervisor: Dr. Maria Pia Ferraz

Co-supervisor: Prof. Dr. Fernando Monteiro

Prof. Dr. Luís Melo

Dr. Olga Nunes

Dr. Cândida Manuel

All Biocomposites Group

Liliana Grenho

Ângela Carvalho

LabE007 colleagues

Project NaNOBiofilm

(PTDC/SAU-BMA/111233/2009) Funding

0,0%

29,5%

77,6%

100,0% 100,0%

0

10

20

30

40

50

60

70

80

90

100

nanoHA830 5 mg/L CHX + nanoHA830

100 mg/L CHX + nanoHA830

500 mg/L CHX + nanoHA830

1500 mg/L CHX + nanoHA830

Per

cen

tage

of

anti

-ad

hes

ive

pro

per

ty (

%)

Surfaces